Delivery Order SPE2DE24D0013-SPE2D625F7SG1
- Not listed
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a $20,400 firm fixed-price delivery order to Cepheid Inc. on July 10, 2025, with an ultimate completion date of July 17, 2025. The contract, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic systems, will perform the work at its...
- The U.S. Defense Department's Medical Supply Chain awarded a $7,480 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, on September 5, 2025, with completion targeted for September 19, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside designation and represents a continuation of Cepheid's...
- The U.S. Defense Department's Medical Supply Chain awarded a $204,000 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 15, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 22, 2025, and carries no set-aside designation. This award represents a continuation of the department's partnership with Cepheid to procure diagnostic testing solutions, specifically for...
- The U.S. Defense Department's Medical Supply Chain awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $20,400 on August 11, 2025, with an ultimate completion date of August 18, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV)—infectious diseases commonly detected through Cepheid's GeneXpert molecular...
- The U.S. Department of Defense's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 10, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 17, 2025, and carries no set-aside designation. The contract nomenclature indicates the order involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $2,040 to Cepheid Inc., a leading molecular diagnostics manufacturer based in Sunnyvale, California, on August 27, 2025. This firm fixed-price delivery order, designated 4569235830 and titled XPCOV2/FLU/RSV-10, is scheduled for completion by September 4, 2025, and carries no set-aside designation. The contract leverages Cepheid's expertise in advanced diagnostic systems and test kits, with the product...
- The U.S. Defense Department's Medical Supply Chain awarded a $2,960 firm fixed-price delivery order to Cepheid Inc. on September 17, 2025, with an ultimate completion date of September 24, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular diagnostic systems and test kits for infectious diseases,...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, on September 10, 2025. The delivery order, designated XPCOV2/FLU/RSV-10 with an ultimate completion date of September 17, 2025, carries no set-aside designation. This award represents a procurement of diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. on May 19, 2025, with completion targeted for May 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV)—infectious disease testing capabilities aligned with federal pandemic preparedness and ongoing surveillance needs. The order carries no set-aside designation and...
- The U.S. Defense Logistics Agency (under the Medical Supply Chain function) awarded a $6,800 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on August 18, 2025, with an ultimate completion date of August 25, 2025, is designated as XPCOV2/FLU/RSV-10 and carries no set-aside designation. The award reflects Cepheid's specialized expertise in providing rapid molecular diagnostic testing for...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F7SG1Delivery Order
The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $2,040 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on July 21, 2025, with an ultimate completion date of July 28, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is structured as a firm fixed-price contract with no set-aside designation and utilizes standard federal pricing mechanisms. This award represents procurement activity under Cepheid's existing indefinite delivery vehicle contracts with the Department of Veterans Affairs, which provide access to the company's molecular diagnostic testing systems, reagents, and assays for infectious disease detection and clinical testing applications. Cepheid specializes in providing advanced diagnostic solutions for detecting COVID-19, influenza, respiratory syncytial virus (RSV), and other infectious diseases across federal healthcare systems. The company maintains significant IDV contracts with VA networks, including a $32.8 million vehicle with Veterans Integrated Service Network 6 and a $2.5 million contract with Veterans Integrated Service Network 21, both supporting PCR testing and laboratory microbiology services through 2030. This delivery order contributes to the Department of Defense's medical supply chain capabilities by providing targeted diagnostic testing resources for infectious disease surveillance and patient care within the defense healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 7/21/25 |